ArticleClinicoEconomics and outcomes research : CEOR2025

Retrospective Study of Real-World Treatment Patterns of Subcutaneous Semaglutide Use Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in the United States.

Yestle Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.